Clinical Trials Directory

Trials / Completed

CompletedNCT07394491

Intravenous Paracetamol Versus Intramuscular Tramadol in Shortening the Duration of Labour.

Intravenous Paracetamol Versus Intramuscular Tramadol in Shortening the Duration of Labour: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
189 (actual)
Sponsor
Federal Teaching Hospital Abakaliki · Other Government
Sex
Female
Age
16 Years – 40 Years
Healthy volunteers
Accepted

Summary

It is a well established fact that the pain of labour can be excrutiating and ways to shorten the duration of labour has been sought after. this study compares the role of intramuscular tramadol and intravenous paracetamol in shortening the duration of labour

Detailed description

Background: The excruciating pain associated with labour as led to different studies aimed at finding pharmacolologic and non pharmacologic ways of shortening the duration of labour. Most agents used are either expensive or associated with fetomaternal adverse effects. This has led to the study of paracetamol and tramadol that have analgesic properties and have shown to have effect on labour duration. Aim: To compare intravenous paracetamol versus intramuscular tramadol in shortening the duration of labour at Alex Ekwueme Federal University Teaching Hospital and St Patrick's Mile 4 Hospital, Abakaliki, Ebonyi State. Methodology: It is an open label, non inferiority randomized controlled trial that was conducted on one hundred and eighty-nine parturients in active labour. Group A received 1000mg of intravenous paracetamol while Group B received 100mg of intramuscular tramadol and allocation was in the ratio of 1:1. Labour duration in the active phase was noted. Data were analyzed using SPSS version 25.

Conditions

Interventions

TypeNameDescription
DRUGparacetamol1000 mg of paracetamol was administered intravenously to participants in active phase of labour
DRUGTramadol hydrochloride100mg of tramadol given in active phase of labour

Timeline

Start date
2022-11-01
Primary completion
2023-02-25
Completion
2023-02-25
First posted
2026-02-06
Last updated
2026-02-06

Locations

1 site across 1 country: Nigeria

Source: ClinicalTrials.gov record NCT07394491. Inclusion in this directory is not an endorsement.